ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Decreased Cardiotoxicity With Infusional Doxorubicin"
Episode Synopsis
We return to our Landmarks of OncoPharm series to dive deep into an article that provided some of our foundational understanding of how anthracycline cardiotoxicity risk is influenced by rate of administration.
Link: https://pubmed.ncbi.nlm.nih.gov/2910423/
Link: https://pubmed.ncbi.nlm.nih.gov/2910423/
More episodes of the podcast OncoPharm
Bladder Cancer Updates & SC Amivantamab
18/12/2025
ASH 2025
11/12/2025
DPYD Deficiency Testing
04/12/2025
Cornucopia of Autumn Updates
26/11/2025
PGYNone: Dandelion Effect
20/11/2025
PGY1 Pathway: Road Trip!
13/11/2025
PGY2 Pathway: A Planned City
06/11/2025
Tale from the Crypt: Belantamab Mafodotin
30/10/2025
ESMO 2025
23/10/2025
IL-2
16/10/2025
In God we trust